Two years after a push for more transparency in the costs of insulin for diabetes treatment, state Sen. Yvanna Cancela is hoping to shed even more light on prescription drug prices and the health care system in Nevada
Two years after a push for more transparency in the costs of insulin for diabetes treatment, state Sen. Yvanna Cancela is hoping to shed even more light on prescription drug prices and the health care system in Nevada